Cairo – Mubasher: The ordinary general meeting (OGM) of Glaxo SmithKline (GSK Egypt) approved a cash dividend of EGP 0.50 per share for 2020.

The shareholders also approved increasing the number of board members to nine and forming a committee to study the financial and legal aspects of the merger with Amoun Pharmaceutical Industries, according to a bourse disclosure on Thursday.

In 2020, GSK Egypt achieved net profits of EGP 28.13 million, down from EGP 142.6 million in 2019, excluding minority shareholders’ rights.